BioMarin Pharmaceutical
BMRN
#1442
Rank
S$16.22 B
Marketcap
$85.15
Share price
-3.32%
Change (1 day)
-27.55%
Change (1 year)

Earnings for BioMarin Pharmaceutical (BMRN)

Earnings in 2024 (TTM): S$0.51 Billion

According to BioMarin Pharmaceutical's latest financial reports the company's current earnings are S$2.75 Billion. In 2023 the company made an earning of S$0.25 Billion, an increase over its 2022 earnings that were of S$0.20 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BioMarin Pharmaceutical from 1999 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) S$0.51 B105.14%
2023 S$0.25 B26.07%
2022 S$0.20 B-298.51%
2021 -S$0.11 Billion78.04%
2020 -S$56.83 Million-55.36%
2019 -S$0.13 Billion-33.56%
2018 -S$0.2 Billion297.78%
2017 -S$48.17 Million-95.68%
2016 -S$1.12 Billion437.12%
2015 -S$0.21 Billion23.91%
2014 -S$0.17 Billion-29.25%
2013 -S$0.24 Billion49.23%
2012 -S$0.16 Billion171.11%
2011 -S$58.58 Million103.01%
2010 -S$28.86 Million-3903.54%
2009 S$0.75 M-98.31%
2008 S$44.87 M-189.7%
2007 -S$50.03 Million51.02%
2006 -S$33.13 Million-61.58%
2005 -S$86.22 Million-56.59%
2004 -S$0.2 Billion95.13%
2003 -S$0.11 Billion12.09%
2002 -S$90.8 Million73.19%
2001 -S$52.43 Million18.32%
2000 -S$44.31 Million19.65%
1999 -S$37.04 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-S$0.7 Billion-232.85%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$0.28 Billion-152.74%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$54.65 Million-110.40%๐Ÿ‡บ๐Ÿ‡ธ USA
S$9.94 B 1,792.41%๐Ÿ‡ซ๐Ÿ‡ท France
-S$0.14 Billion-125.51%๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.12 B-76.10%๐Ÿ‡บ๐Ÿ‡ธ USA